W. Bradford Smith - Jan 9, 2023 Form 4 Insider Report for Homology Medicines, Inc. (FIXX)

Role: Chief Financial and Business Officer and Treasurer
Signature: /s/ W. Bradford Smith
Stock symbol: FIXX
Transactions as of: Jan 9, 2023
Transactions value $: -$5,188
Form type: 4
Date filed: 1/11/2023, 03:05 PM
Previous filing: Jan 4, 2023
Next filing: Feb 27, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FIXX	Common Stock	Sale	-$5.19K	-3.73K	-20.78%	$1.39	14.2K	Jan 9, 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of restricted stock units.
F2	The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $1.39 to $1.41. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 2.

Remarks:

Chief Financial and Business Officer and Treasurer